SEC Form 4 · accession 0001209191-18-023744
AveXis, Inc. · AVXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Litalien
Officer — SrVP/Chief Reg&Quality Officer
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001652923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2018 | M | 5,000 | $18.17 | A | 8,800 | D | |
| Common StockF2 | Apr 2, 2018 | S | 1,170 | $117.10 | D | 7,630 | D | |
| Common StockF3 | Apr 2, 2018 | S | 569 | $118.41 | D | 7,061 | D | |
| Common StockF4 | Apr 2, 2018 | S | 1,297 | $119.43 | D | 5,764 | D | |
| Common StockF5 | Apr 2, 2018 | S | 1,052 | $120.11 | D | 4,712 | D | |
| Common StockF6 | Apr 2, 2018 | S | 757 | $122.14 | D | 3,955 | D | |
| Common StockF7 | Apr 2, 2018 | S | 155 | $123.32 | D | 3,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F8 | $18.17 | Apr 2, 2018 | M | 5,000 | D | — | Aug 11, 2025 | Common Stock | 5,000 | 141,800 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on September 13, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.90 to $117.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.90 to $118.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.94 to $119.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.94 to $120.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.95 to $122.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.97 to $123.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
- F837,950 shares vested and became exercisable on July 20, 2016; the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter until July 20, 2019, subject to the Reporting Person's continuous service with the Issuer on each such date.